Zinc Restored the Decreased Vascular Smooth Muscle Cell Viability under Atherosclerotic Calcification Conditions

  • Shin, Mee-Young (Department of Food Science and Nutrition, College of Human Ecology, Andong National University) ;
  • Kwun, In-Sook (Department of Food Science and Nutrition, College of Human Ecology, Andong National University)
  • Received : 2014.12.01
  • Accepted : 2014.12.07
  • Published : 2014.12.31


Zinc is considered to be involved in maintaining healthy vascular condition. Atherosclerotic calcification of vascular smooth muscle cells (VSMCs) occurs via the mechanism of cell death; therefore, cell viability is a critical factor for preventing VSMC calcification. In this study, we tested whether zinc affected VSMC viability under both normal physiological non-calcifying (0 mM P) and atherosclerotic calcifying conditions (3 and 5 mM P), since VSMC physiological characters change during the VSMC calcification process. The study results showed that an optimal zinc level ($15{\mu}M$) restored the decreased VSMC viability which was induced under low zinc levels (0 and $1{\mu}M$) and calcifying conditions (3 and 5 mM P) at 9 and 15 days culture. This zinc-protecting effect for VSMC viability is more prominent under atherosclerotic calcifying condition (3 and 5 mM P) than normal condition (0 mM P). Also, the increased VSMC viability was consistent with the decreased Ca and P accumulation in VSMC cell layers. The results suggested that zinc could be an effective biomineral for preventing VSMC calcification under atherosclerotic calcifying conditions.


Supported by : National Research Foundation of Korea


  1. Wu M, Rementer C, Giachelli CM. 2013. Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int 93: 365-373.
  2. McCarthy NJ, Bennett MR. 2000. The regulation of vascular smooth muscle cell apoptosis. Cardiovasc Res 45: 747-755.
  3. Kim KM. 1995. Apoptosis and calcification. Scanning Microsc 9: 1137-1178.
  4. Hashimoto S, Ochs RL, Rosen F, Quach J, McCabe G, Solan J, Seegmiller JE, Terkeltaub R, Lotz M. 1998. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 95: 3094-3099.
  5. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. 2000. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Cric Res 87: 1055-1062.
  6. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. 2005. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 96: 717-722.
  7. Bremner I, Beattie JH. 1995. Copper and zinc metabolism in health and disease: speciation and interactions. Proc Nutr Soc 54: 489-499.
  8. Beattie JH, Kwun IS. 2004. Is zinc deficiency a risk factor for atherosclerosis? Brit J Nutr 91: 177-181.
  9. Allen-Redpath K, Ou O, Beattie JH, Kwun IS, Feldmann J, Nixon GF. 2013. Marginal dietary zinc deficiency in vivo induces vascular smooth muscle cell apoptosis in large arteries. Cardiovasc Res 99: 525-534.
  10. Bennett MR. 1999. Apoptosis of vascular smooth muscle cells in vascular remodeling and atherosclerotic plaque rupture. Cardiovasc Res 41: 361-368.
  11. Ou O, Allen-Redpath K, Urgast D, Gordon MJ, Campbell G, Feldmann J, Nixon GF, Mayer CD, Kwun IS, Beattie JH. 2013. Plasma zinc's alter ego is a low-molecular-weight humoral factor. FASEB J 27: 3672-3682.

Cited by

  1. Nutrition and Atherosclerosis vol.46, pp.5, 2015,